文献速递泌尿系结石

腔内泌尿外科手术中对比剂过敏预防使用趋势

Trends in the Usage of Contrast Allergy Prophylaxis for Endourologic Procedures.
PubMed 文献 · Urology · 2019-05-25

这项调查向腔内泌尿外科学会全体成员发放问卷,评估输尿管镜(URS)和经皮肾镜取石术(PCNL)前静脉对比剂过敏的管理模式。应答率15%(325/2100),21%和28%的受访者分别在URS和PCNL前给予预防用药,近3%曾观察到严重不良反应,约半数仅在术前1小时给药。多数泌尿外科医生不在URS和PCNL前给予预防用药,需进一步研究评估预防的必要性并建立明确指南。

要点

  • 21%和28%的受访者分别在URS和PCNL前给予对比剂过敏预防。
  • 约半数受访者仅在术前1小时给予预防用药。
  • 预防给药与URS或PCNL手术量显著相关(URS X2=8.3,P=.004;PCNL X2=8.5,P=.003)。

核心结论

  • 多数泌尿外科医生不在URS和PCNL前对静脉对比剂过敏患者给予预防用药。
  • 需进一步研究评估预防的必要性并建立明确指南。

研究设计与样本

  • 向腔内泌尿外科学会全体成员发放问卷调查。
  • 评估URS和PCNL前静脉对比剂过敏的管理,并收集治疗方案、不良结局报告和受访者人口学资料。
  • 数据分析采用卡方检验。
  • 应答率为15%(325/2100)。

主要发现

  • 21%的受访者在URS前给予预防用药,28%的受访者在PCNL前给予预防用药。
  • 近3%的受访者报告过去曾观察到腔内对比剂的严重不良反应。
  • 约半数受访者仅在术前1小时给予预防用药。
  • 77%的受访者完成专科培训,其中最常见的是腔内泌尿外科。
  • 预防给药与URS手术量显著相关(X2=8.3,P=.004),与PCNL手术量显著相关(X2=8.5,P=.003),手术量最低和最高的泌尿外科医生更可能给予预防。

局限性

  • 需进一步研究评估预防的必要性并建立明确指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize current practice patterns of urologists in the management of intravenous (IV) contrast allergy in the setting of endourologic procedures. METHODS: A survey was administered to all members of the Endourological Society to assess management of IV contrast allergy prior to ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL). Treatment regimens, reports of adverse outcomes, and demographics of respondents were also collected. Data were analyzed using chi-square tests. RESULTS: The response rate was 15% (325/2100). A total of 21% and 28% of respondents reported giving prophylaxis prior to URS and PCNL, respectively. Nearly 3% of respondents reported having observed a severe adverse reaction to intraluminal contrast in the past. Approximately half reported giving prophylaxis only 1 hour prior to the procedure. Most respondents (77%) completed a fellowship, the most common being endourology. Chi-square analysis revealed a significant difference between giving prophylaxis for URS or PCNL and the respective case volumes (for URS, X2 = 8.3, P= .004; for PCNL, X2 = 8.5, P= .003) where urologists with the lowest and highest case volumes were more likely to give prophylaxis (Fig. 1). There was no significant difference between giving prophylaxis for URS or PCNL and recency of residency, fellowship training, practice setting, or practice type. CONCLUSION: Most urologists do not give prophylaxis for patients with IV contrast allergy prior to URS and PCNL. Further studies are needed to evaluate the necessity of prophylaxis as well as to establish clear guidelines.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Mohapatra A, Hyun G, Semins MJ, et al. Trends in the Usage of Contrast Allergy Prophylaxis for Endourologic Procedures. Urology. 2019. PMID: 31132426. doi:10.1016/j.urology.2019.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。